---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-242526"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2023-09-26T23:59:59+00:00"
generated_at: "2026-06-10T08:32:52.339682+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma FY2023 net loss $31.8M; cash $100.7M; merger fails, CEO changed

## Summary
- Net loss $31.8M ($4.78/share) vs $54.5M ($8.75/share) prior year; revenue $48.8M, up from $40.7M.
- Cash and equivalents $100.7M, no debt; cash used in operations $52.5M.
- Stockholders rejected Infinity Pharmaceuticals merger (47.86% for, 51.44% against); agreement terminated.
- David M. Urso appointed CEO (June 2023); Jay File appointed CFO (effective Aug 2023).
- Voruciclib+venetoclax data early 2024; ME-344+bevacizumab data H1 2024; workforce reduced 61% to 41 employees.

## SEC filing metadata
- accession: 0001193125-23-242526
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2023-09-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000119312523242526/0001193125-23-242526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000119312523242526/d548878d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-242526
- JSON: https://secwatch.observer/filing/0001193125-23-242526.json
- Plain text: https://secwatch.observer/filing/0001193125-23-242526.txt

## Key facts
- Earnings Releases
  Lite Strategy, Inc. reported financial results for fiscal year ended June 30, 2023.
  - Period: fiscal year ended June 30, 2023
  - Result: reported results
  source text: On September 26, 2023, MEI Pharma, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal year ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1262104/000119312523242526/0001193125-23-242526-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.